申请人:Nakamura Yoshinori
公开号:US20090029994A1
公开(公告)日:2009-01-29
The present invention relates to a compound of the general formula (1):
wherein, Y is a methylene group, and the like; A is an optionally substituted heterocyclic group, and the like; B is an optionally substituted phenyl group, and the like; R
1
is an optionally substituted alkyl group, and the like; and R
2
is an optionally substituted amino group, and the like; or a pharmaceutically acceptable derivative thereof, which has an inhibitory activity against cholesteryl ester transfer protein (CETP), thereby being useful for prophylaxis and/or treatment of arteriosclerotic diseases, hyperlipemia or dyslipidemia, and the like.
本发明涉及一般式(1)的化合物,其中Y是亚甲基基团等;A是可选择取代的杂环基团等;B是可选择取代的苯基团等;R1是可选择取代的烷基团等;R2是可选择取代的氨基团等;或其药学上可接受的衍生物,该化合物具有胆固醇酯转移蛋白(CETP)的抑制活性,因此可用于动脉粥样硬化疾病、高脂血症或异常脂质血症的预防和/或治疗等。